Written and maintained by CASRAI Editorial Board
Last updated
A qualitative RT-PCR returns a categorical answer, target detected or not detected, rather than an amount. For a real-time assay the answer comes from whether a fluorescence curve crosses a threshold within a set number of cycles, and only if the run’s controls behaved as expected. This page is general laboratory information, not medical advice; it does not interpret any individual person’s result.
Short answer
Qualitative RT-PCR reverse transcribes RNA to cDNA, amplifies a target, and reports whether the target was detected. Each assay defines its own rules for positive, negative, inconclusive and invalid, written in its instructions for use (IFU). A worked example from one published IFU is laid out below.
Definition and scope
RT-PCR combines reverse transcription (RNA to cDNA) with PCR amplification. The reverse transcription step can share the tube with the PCR (one-step) or be run first as a separate reaction whose cDNA is then added to the PCR (two-step), as described by Wacker and Godard (2005). Our guide to reverse transcription PCR covers that chemistry, and the nucleic acid amplification test guide places RT-PCR among other amplification methods.
“Qualitative” describes what the assay reports, not a different chemistry. The CDC 2019-nCoV Real-Time RT-PCR Diagnostic Panel, for example, is described in its IFU as a real-time RT-PCR test intended for the qualitative detection of nucleic acid from SARS-CoV-2, using dual-labeled hydrolysis (TaqMan) probes whose fluorescence is read each cycle. See TaqMan qPCR for how those probes work.
How a qualitative call is made: one assay’s rules
The table below restates the interpretation section of the CDC IFU (CDC-006-00019, Rev 08, effective 7 March 2023). It applies only when the run controls are valid, and it is one product’s rule set, not a universal cutoff. The assay targets two regions of the viral N gene (N1, N2) and the human RNase P gene (RP), which indicates that human material was present.
| Viral targets N1 and N2 | RNase P | Call in the IFU |
|---|---|---|
| Both cross the threshold within 40.00 cycles | Positive or negative | Positive (RP may or may not be positive; the result is still valid) |
| Neither crosses within 40.00 cycles | Crosses within 40.00 cycles | Negative |
| Neither crosses within 40.00 cycles | Does not cross | Invalid: re-test the extracted RNA, re-extract if needed, and consider a new specimen if still negative for all targets |
| Only one of N1 or N2 crosses within 40.00 cycles | Any | Inconclusive: re-test the extracted RNA |
Run controls come first
- No-template control (nuclease-free water in place of RNA): should show no curve crossing the threshold. If it does, the IFU says sample contamination may have occurred and the run is invalidated.
- Positive control: expected positive for N1, N2 and RNase P at below 40.00 Ct.
- Extraction control: expected negative for N1 and N2 and positive for RNase P at below 40.00 Ct.
If the controls do not perform as expected, the IFU directs the lab to invalidate the run and re-test. The call for any specimen is therefore never read from its curves alone. For how the cycle threshold itself behaves, see Ct values in qPCR.
RT-PCR vs RT-qPCR: a naming cross-walk
What is the difference between RT-qPCR and RT-PCR?
The terms overlap. “RT-PCR” can mean any PCR preceded by reverse transcription; “RT-qPCR” stresses real-time fluorescence monitoring, usually for quantification. Wacker and Godard use “real-time, or quantitative reverse transcription polymerase chain reaction (RT-PCR)” interchangeably, which shows why readers meet both labels for the same instrument workflow. A real-time assay can be run qualitatively, as the CDC panel is, by applying a cutoff and reporting detected or not detected. For quantification, standard curves and reporting practice, see qPCR and RT-qPCR.
| Label | What it usually emphasises |
|---|---|
| RT-PCR | Reverse transcription followed by PCR; does not by itself say whether the readout is real-time or quantitative |
| Real-time RT-PCR | Fluorescence read every cycle (the CDC IFU calls its panel a real-time RT-PCR test) |
| RT-qPCR | Real-time RT-PCR, with the “q” signalling quantitative use |
| Qualitative RT-PCR | Reports detected or not detected against a defined cutoff |
Where it matters for labs
- Cutoffs, control acceptance criteria and retest rules belong to the validated assay; a lab uses the values in the IFU for the product and version in use, not figures borrowed from another assay.
- Invalid and inconclusive are distinct outcomes with different retest paths, so records should capture which one occurred and why.
- A failed no-template control is a contamination signal for the whole run, not for one well.
- The IFU version matters: the example above is Rev 08, and rules can change between revisions.
Common misunderstandings
- “Qualitative means less accurate.” It means the output is categorical. Performance is a separate question, answered by validation data.
- “One target crossing is enough.” Under the example IFU, only one of two viral targets crossing is inconclusive, not positive.
- “A negative means nothing was checked.” A valid negative in the example requires RNase P to cross, which is what separates it from an invalid result.
- “Every assay uses 40 cycles.” The 40.00 Ct limit is this assay’s; other assays define their own.
FAQ
What is polymerase chain reaction?
PCR is a method that copies a defined DNA region through repeated cycles of heating and cooling, so that a small amount of target becomes detectable. In RT-PCR the starting material is RNA, which is first converted to cDNA.
What does it mean to be PCR positive?
In an assay like the example above, positive means the target’s amplification signal crossed the threshold within the cycle limit with valid controls. It reports detection of nucleic acid by that assay; what it means for a person is a clinical question for a clinician.
How to interpret PCR results?
Read them against the specific assay’s IFU: check control results first, then the target and sample-adequacy signals, then apply the stated call rules. This page gives general laboratory information only and does not interpret personal results; ask the ordering clinician or testing laboratory about a specific result.
What is qualitative RT-PCR used for?
It answers presence or absence questions, such as the detection of SARS-CoV-2 RNA in respiratory specimens in the CDC example.
Sources
- CDC, 2019-Novel Coronavirus (2019-nCoV) Real-Time RT-PCR Diagnostic Panel, Instructions for Use, CDC-006-00019 Rev 08, effective 7 March 2023, hosted by FDA: fda.gov/media/134922/download (read 7 November 2026).
- Wacker MJ, Godard MP. J Biomol Tech 2005;16(3):266-271: PMC2291734 (read 7 November 2026).
